incb057643
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2016 (NCT02711137)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- incb057643
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06941077 | Phase 1 | May 12, 2025 | Incyte |
| NCT06619522 | Phase 2 | Mar 1, 2025 | University of Texas at Houston |
| NCT04279847 | Phase 1 | May 31, 2020 | Incyte |
| NCT02711137 | Phase 1/Phase 2 (Phase 2) | May 1, 2016 | Incyte |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Incyte | For profit | 3 | 3 | 2 | 2016 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1